Bay State Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Bay State Times.

Press releases published on June 1, 2026

Jun. 1, 2026

Interisle Study Finds Malicious Actors Accounted for 10-20% of New Domain Name Registrations in 2025

Indeterminate EIN Presswire

Jun. 1, 2026

Cognisee Convenes 'Superintelligence for Humanity' Summit to Advance Artificial Collective Intelligence

Indeterminate EIN Presswire

Jun. 1, 2026

Elder-Well® Adult Day Program Expands to Oregon With Seth And Breanna Dickinson, CSA®

Indeterminate EIN Presswire

Jun. 1, 2026

Lydonia Sponsors Insurance Tech & Innovation Conference, Advancing Insurance Industry Expertise in AI Transformation

Indeterminate EIN Presswire

Jun. 1, 2026

Valiant Funds’ Mining Partner Secures Strategic Agreement to Enhance Cost Efficiency and Drive Investor Value

Indeterminate EIN Presswire

Jun. 1, 2026

Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 1, 2026

Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 1, 2026

X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 1, 2026

Praxis Precision Medicines Provides Vormatrigine Program Update

Indeterminate GlobeNewswire

Jun. 1, 2026

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 1, 2026

Minerva Neurosciences Establishes Scientific Advisory Board to Advance Development of Roluperidone and Future Pipeline Programs

Indeterminate GlobeNewswire

Jun. 1, 2026

Merlin, Inc. To Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Jun. 1, 2026

Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 1, 2026

Fulcrum Therapeutics Announces Discontinuation of Pociredir Program in Sickle Cell Disease and Initiation of Strategic Review

Indeterminate GlobeNewswire

Jun. 1, 2026

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 1, 2026

Keros Therapeutics Announces Participation at Goldman Sachs 47th Annual Global Healthcare Conference

Indeterminate GlobeNewswire

Jun. 1, 2026

E Ink Debuts 75-inch Color ePaper Advertising Display at Taoyuan International Airport

Indeterminate GlobeNewswire

Jun. 1, 2026

Origin Medical Announces Leadership Transition and Expands Executive Team Ahead of Commercial Launch

Indeterminate GlobeNewswire

Jun. 1, 2026

Alpha Tau Announces Strong Overall Survival Results from Alpha DaRT® Pancreatic Cancer Studies Presented at 2026 ASCO Annual Meeting

Indeterminate GlobeNewswire

Jun. 1, 2026

Sophos and Rubrik Make Microsoft 365 Backup and Recovery, Powered by Rubrik Cyber Resilience, Available to Sophos Customers Worldwide

Indeterminate GlobeNewswire